These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22633434)

  • 1. Relation between poststenting peristent plaque components and late stent malapposition after drug-eluting stent implantation: virtual histology-intravascular ultrasound analysis.
    Hong YJ; Jeong MH; Choi YH; Song JA; Jang SY; Yoo JH; Song JE; Lee KH; Yamanaka F; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Int J Cardiol; 2013 Sep; 167(5):1882-7. PubMed ID: 22633434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up.
    Hong MK; Mintz GS; Lee CW; Park DW; Park KM; Lee BK; Kim YH; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Park SW; Park SJ
    Circulation; 2006 Jan; 113(3):414-9. PubMed ID: 16432073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late and very late drug-eluting stent malapposition: serial 2-year quantitative IVUS analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2010 Aug; 3(4):335-40. PubMed ID: 20606134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of preinterventional plaque composition and eccentricity on late-acquired incomplete stent apposition after sirolimus-eluting stent implantation: an intravascular ultrasound radiofrequency analysis.
    Sato T; Kameyama T; Noto T; Nozawa T; Inoue H
    Coron Artery Dis; 2012 Nov; 23(7):432-7. PubMed ID: 22936019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
    Guo N; Maehara A; Mintz GS; He Y; Xu K; Wu X; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW
    Circulation; 2010 Sep; 122(11):1077-84. PubMed ID: 20805433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study.
    van der Hoeven BL; Liem SS; Dijkstra J; Bergheanu SC; Putter H; Antoni ML; Atsma DE; Bootsma M; Zeppenfeld K; Jukema JW; Schalij MJ
    JACC Cardiovasc Interv; 2008 Apr; 1(2):192-201. PubMed ID: 19463300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.
    Cook S; Ladich E; Nakazawa G; Eshtehardi P; Neidhart M; Vogel R; Togni M; Wenaweser P; Billinger M; Seiler C; Gay S; Meier B; Pichler WJ; Jüni P; Virmani R; Windecker S
    Circulation; 2009 Aug; 120(5):391-9. PubMed ID: 19620501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation.
    Hong MK; Mintz GS; Lee CW; Kim YH; Lee SW; Song JM; Han KH; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
    Circulation; 2004 Feb; 109(7):881-6. PubMed ID: 14967732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents.
    Kang SJ; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Shimizu T; Xu K; Kirtane AJ; Stone GW; Maehara A
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25552564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.
    Claessen BE; Beijk MA; Legrand V; Ruzyllo W; Manari A; Varenne O; Suttorp MJ; Tijssen JG; Miquel-Hebert K; Veldhof S; Henriques JP; Serruys PW; Piek JJ
    Circ Cardiovasc Interv; 2009 Aug; 2(4):339-47. PubMed ID: 20031737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation.
    Hong SJ; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2015 Nov; 56(6):1538-44. PubMed ID: 26446634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated plaque is associated with plaque prolapse accompanied by cardiac enzyme elevation after drug-eluting stent implantation.
    Wu XF; Guo CJ; Chi YP; Yang Y; Lu R; He DF; Zhang XJ
    Coron Artery Dis; 2014 Jan; 25(1):4-9. PubMed ID: 24158145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
    Mizoguchi T; Sawada T; Shinke T; Yamada S; Okamoto H; Kim SS; Takarada A; Yasaka Y
    Int J Cardiol; 2014 Feb; 171(2):224-30. PubMed ID: 24388538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.
    Sakata K; Waseda K; Kume T; Otake H; Nakatani D; Yock PG; Fitzgerald PJ; Honda Y
    Circ Cardiovasc Interv; 2012 Dec; 5(6):763-71. PubMed ID: 23149332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation.
    Kang SJ; Cho YR; Park GM; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Park SW; Park SJ
    Am J Cardiol; 2013 May; 111(10):1408-14. PubMed ID: 23433757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.